Tag: Bristol-Myers Squibb Co

‘Mag 7’ earnings, Fed meeting will test a stock market near all-time highs. Here’s what’s ahead

Here’s our monthly update on all 31 portfolio stocks, including 3 on the buy list

Trump tariff fallout: Some industries grapple with lingering effects one year later

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

Here’s an update on our 4th Industrial Revolution stocks and the rest of the portfolio

With Trump’s ‘reciprocal’ tariffs struck down, here are the industries still facing higher rates

Healthy Returns: Botox, Trulicity among 15 drugs added to Medicare price negotiations

Another alliance of health care and AI signals why pharma stocks should be back in favor

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference